Skip to content
Recall Observatory FDA recall evidence

Drug product

Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10.

D-0237-2026

November 26, 2025

Class III

Product summary

Firm
SOMERSET THERAPEUTICS LLC
Event
Event 98063
Status
Ongoing
Classification
Class III
Quantity
28,660 20mL vials
Official record key
drug-enforcement:D-0237-2026

Official wording

Reason: Subpotent product:out of specification assay results observed during long term stability testing.

Code information: Lot #: A250020, Exp Date 06/30/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent